Ophthalmic Business

  Alcon will expand its femtosecond laser-assisted cataract surgery offerings with a deal to acquire Lensar, according to a press release.

ORLANDO — In this Healio Video Perspective from Vision Expo East, Yair Yahav, CEO and founder of RevitalVision, discusses the U.S. launch of the company’s neurological therapy indicated to improve vision outcomes across various conditions.

ORLANDO — In this Healio Video Perspective from Vision Expo East, Trudi Charest discusses the importance of building a personal online brand as an eye care professional.

ORLANDO — In this Healio Video Perspective, Ashley Mills, CEO of The Vision Council, co-owner of Vision Expo East, provides a preview of this year’s event, including new opportunities and experiences.

The FDA approved Susvimo for the treatment of diabetic macular edema, according to a press release.

Adam Szaronos has been appointed as CEO of Iantrek, succeeding Sean Ianchulev, MD, MPH, according to a press release.

Lynx, Norlase’s pattern scanning laser indirect ophthalmoscope, commercially launched with both FDA 510(k) clearance and a CE mark, according to a press release.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Ben Burton of iuvo Bioscience sheds light on how the acquisition of the company’s lab services by Canyon Labs will aid its mission to drive ophthalmic research.

Healio and Mathematica, a research and data analytics consultancy, have partnered to launch Healio PRICE Compass, a pricing transparency tool developed by Mathematica that will allow ophthalmologists to see contracted rates for payers.

The K8 implant, a first-in-class dual inflammasome inhibitor, demonstrated positive efficacy and safety at 3 months in five patients with bilateral geographic atrophy, according to a press release from Inflammasome Therapeutics.